Literature DB >> 15067211

Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Zhi-Ming Zheng1.   

Abstract

Intron removal from a pre-mRNA by RNA splicing was once thought to be controlled mainly by intron splicing signals. However, viral and other eukaryotic RNA exon sequences have recently been found to regulate RNA splicing, polyadenylation, export, and nonsense-mediated RNA decay in addition to their coding function. Regulation of alternative RNA splicing by exon sequences is largely attributable to the presence of two major cis-acting elements in the regulated exons, the exonic splicing enhancer (ESE) and the suppressor or silencer (ESS). Two types of ESEs have been verified from more than 50 genes or exons: purine-rich ESEs, which are the more common, and non-purine-rich ESEs. In contrast, the sequences of ESSs identified in approximately 20 genes or exons are highly diverse and show little similarity to each other. Through interactions with cellular splicing factors, an ESE or ESS determines whether or not a regulated splice site, usually an upstream 3' splice site, will be used for RNA splicing. However, how these elements function precisely in selecting a regulated splice site is only partially understood. The balance between positive and negative regulation of splice site selection likely depends on the cis-element's identity and changes in cellular splicing factors under physiological or pathological conditions. Copyright 2004 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067211      PMCID: PMC2442652          DOI: 10.1007/bf02254432

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  183 in total

1.  Correlation between severity and SMN protein level in spinal muscular atrophy.

Authors:  S Lefebvre; P Burlet; Q Liu; S Bertrandy; O Clermont; A Munnich; G Dreyfuss; J Melki
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

2.  Functional properties of p54, a novel SR protein active in constitutive and alternative splicing.

Authors:  W J Zhang; J Y Wu
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

3.  A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.

Authors:  J M Yeakley; J P Morfin; M G Rosenfeld; X D Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Architectural limits on split genes.

Authors:  D A Sterner; T Carlo; S M Berget
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  The C-terminal domain of RNA polymerase II couples mRNA processing to transcription.

Authors:  S McCracken; N Fong; K Yankulov; S Ballantyne; G Pan; J Greenblatt; S D Patterson; M Wickens; D L Bentley
Journal:  Nature       Date:  1997-01-23       Impact factor: 49.962

6.  The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.

Authors:  M E Gallego; R Gattoni; J Stévenin; J Marie; A Expert-Bezançon
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

7.  Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.

Authors:  Z Si; B A Amendt; C M Stoltzfus
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

8.  RNA recognition by the human polyadenylation factor CstF.

Authors:  Y Takagaki; J L Manley
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

9.  Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis.

Authors:  P G Zaphiropoulos
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

10.  Identification of a new class of exonic splicing enhancers by in vivo selection.

Authors:  L R Coulter; M A Landree; T A Cooper
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

View more
  82 in total

1.  Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.

Authors:  Dibyakanti Mandal; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

3.  Nonsense-associated alternative splicing of T-cell receptor beta genes: no evidence for frame dependence.

Authors:  Fabio Mohn; Marc Bühler; Oliver Mühlemann
Journal:  RNA       Date:  2004-12-21       Impact factor: 4.942

4.  Genome-wide assembly and analysis of alternative transcripts in mouse.

Authors:  Alexei A Sharov; Dawood B Dudekula; Minoru S H Ko
Journal:  Genome Res       Date:  2005-05       Impact factor: 9.043

5.  Dichotomous splicing signals in exon flanks.

Authors:  Xiang H-F Zhang; Christina S Leslie; Lawrence A Chasin
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

6.  Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Authors:  Emily A Newman; Stephanie J Muh; Ruben H Hovhannisyan; Claude C Warzecha; Richard B Jones; Wallace L McKeehan; Russ P Carstens
Journal:  RNA       Date:  2006-04-07       Impact factor: 4.942

7.  SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.

Authors:  Lei Gao; Junning Wang; Yingzi Wang; Athena Andreadis
Journal:  Mol Cell Neurosci       Date:  2006-11-29       Impact factor: 4.314

8.  Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring gamma-retrovirus-encoded hsvtk suicide genes.

Authors:  X Wang; M Olszewska; V Capacio; J Stefanski; M Przybylowski; S Samakoglu; A H Chang; M Sadelain; I Rivière
Journal:  Gene Ther       Date:  2008-06-19       Impact factor: 5.250

9.  XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Authors:  Sikandar G Khan; Koji Yamanegi; Zhi-Ming Zheng; Jennifer Boyle; Kyoko Imoto; Kyu-Seon Oh; Carl C Baker; Engin Gozukara; Ahmet Metin; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

10.  Alternative splicing attenuates transgenic expression directed by the apolipoprotein E promoter-enhancer based expression vector pLIV11.

Authors:  Dongmei Cheng; Philip S MacArthur; Shunxing Rong; John S Parks; Gregory S Shelness
Journal:  J Lipid Res       Date:  2009-10-27       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.